O Shaughnessy Asset Management LLC lessened its holdings in shares of Centene Co. (NYSE:CNC – Free Report) by 71.1% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 72,394 shares of the company’s stock after selling 178,282 shares during the period. O Shaughnessy Asset Management LLC’s holdings in Centene were worth $4,386,000 at the end of the most recent reporting period.
Several other institutional investors have also recently added to or reduced their stakes in the business. Norges Bank acquired a new stake in Centene during the fourth quarter worth approximately $1,536,167,000. State Street Corp raised its stake in Centene by 0.5% during the 3rd quarter. State Street Corp now owns 23,468,159 shares of the company’s stock worth $1,766,683,000 after acquiring an additional 111,654 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its position in Centene by 3.6% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 3,803,437 shares of the company’s stock valued at $230,412,000 after acquiring an additional 130,895 shares during the last quarter. Amundi boosted its stake in Centene by 77.2% in the fourth quarter. Amundi now owns 2,786,770 shares of the company’s stock valued at $176,040,000 after acquiring an additional 1,214,425 shares in the last quarter. Finally, Prudential Financial Inc. grew its stake in Centene by 80.6% during the 4th quarter. Prudential Financial Inc. now owns 2,080,826 shares of the company’s stock worth $126,056,000 after buying an additional 928,465 shares during the last quarter. Hedge funds and other institutional investors own 93.63% of the company’s stock.
Centene Stock Performance
NYSE CNC opened at $60.69 on Thursday. The business has a 50 day moving average price of $59.79 and a 200 day moving average price of $62.44. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.11 and a quick ratio of 1.10. The company has a market capitalization of $30.10 billion, a P/E ratio of 9.73, a PEG ratio of 0.80 and a beta of 0.40. Centene Co. has a 1-year low of $55.03 and a 1-year high of $80.59.
Analyst Upgrades and Downgrades
CNC has been the subject of several research reports. Barclays upped their price target on shares of Centene from $91.00 to $93.00 and gave the company an “overweight” rating in a research report on Friday, December 13th. Oppenheimer reduced their target price on shares of Centene from $95.00 to $85.00 and set an “outperform” rating for the company in a report on Friday, December 13th. Cantor Fitzgerald reissued an “overweight” rating and set a $90.00 price target on shares of Centene in a report on Wednesday, December 11th. UBS Group raised Centene from a “neutral” rating to a “buy” rating and upped their price objective for the company from $79.00 to $80.00 in a research note on Friday, December 13th. Finally, Wells Fargo & Company lowered their target price on Centene from $76.00 to $72.00 and set an “overweight” rating on the stock in a research note on Friday, February 14th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and ten have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $79.92.
Check Out Our Latest Stock Analysis on Centene
Centene Profile
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Recommended Stories
- Five stocks we like better than Centene
- How to Start Investing in Real Estate
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- What is a buyback in stocks? A comprehensive guide for investors
- The 3 Most Talked About Investments on WallStreetBets Right Now
- How to Use the MarketBeat Dividend Calculator
- Analyst Targets Signal More Growth in CrowdStrike Stock
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Co. (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.